{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T10:38:48Z","timestamp":1789295928219,"version":"build-2803163510"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2019,4,2]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Obesity is a precursor to heart failure with preserved ejection fraction. Biomarkers that identify preclinical metabolic heart disease (\n              <jats:styled-content style=\"fixed-case\">MHD<\/jats:styled-content>\n              ) in young obese patients would help identify high\u2010risk individuals for heart failure prevention strategies. We assessed the predictive value of GAL3 (galectin\u20133), FSTL3 (follistatin\u2010like 3 peptide), and NT\u2010proBNP (N\u2010terminal pro\u2010B\u2010type natriuretic peptide) to identify stage B\n              <jats:styled-content style=\"fixed-case\">MHD<\/jats:styled-content>\n              in young obese participants free of clinically evident cardiovascular disease.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Asymptomatic obese patients (n=250) and non\u2010obese controls (n=21) underwent echocardiographic cardiac phenotyping. Obese patients were classified as\n              <jats:styled-content style=\"fixed-case\">MHD<\/jats:styled-content>\n              positive (\n              <jats:styled-content style=\"fixed-case\">MHD<\/jats:styled-content>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">POS<\/jats:styled-content>\n              ; n=94) if they had abnormal diastolic function or left ventricular hypertrophy and had estimated pulmonary artery systolic pressure \u226535\u00a0mm\u00a0Hg. Obese patients without such abnormalities were classified as MHD negative (MHD\u2010NEG; n=52). Serum biomarkers timed with echocardiography.\n              <jats:styled-content style=\"fixed-case\">MHD<\/jats:styled-content>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">POS<\/jats:styled-content>\n              and MHD\u2010NEG individuals were similarly obese, but\n              <jats:styled-content style=\"fixed-case\">MHD<\/jats:styled-content>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">POS<\/jats:styled-content>\n              patients were older, with more diabetes mellitus and metabolic syndrome. Right ventricular coupling was worse in\n              <jats:styled-content style=\"fixed-case\">MHD<\/jats:styled-content>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">POS<\/jats:styled-content>\n              patients (\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001).\n              <jats:styled-content style=\"fixed-case\">GAL<\/jats:styled-content>\n              3 levels were higher in\n              <jats:styled-content style=\"fixed-case\">MHD<\/jats:styled-content>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">POS<\/jats:styled-content>\n              versus\n              <jats:styled-content style=\"fixed-case\">MHD<\/jats:styled-content>\n              \u2010NEG patients (7.7\u00b12.3 versus 6.3\u00b11.9\u00a0ng\/mL, respectively;\n              <jats:italic>P<\/jats:italic>\n              &lt;0.001). Both\n              <jats:styled-content style=\"fixed-case\">GAL<\/jats:styled-content>\n              3 and\n              <jats:styled-content style=\"fixed-case\">FSTL<\/jats:styled-content>\n              3 levels correlated with diastolic dysfunction and increased pulmonary artery systolic pressure but not with left ventricular mass. In multivariate models including all 3 biomarkers, only\n              <jats:styled-content style=\"fixed-case\">GAL<\/jats:styled-content>\n              3 remained associated with\n              <jats:styled-content style=\"fixed-case\">MHD<\/jats:styled-content>\n              (odds ratio: 1.30; 95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              , 1.01\u20131.68;\n              <jats:italic>P<\/jats:italic>\n              =0.04).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              In young obese individuals without known cardiovascular disease,\n              <jats:styled-content style=\"fixed-case\">GAL<\/jats:styled-content>\n              3 is associated with the presence of preclinical\n              <jats:styled-content style=\"fixed-case\">MHD<\/jats:styled-content>\n              .\n              <jats:styled-content style=\"fixed-case\">GAL<\/jats:styled-content>\n              3 may be useful in screening for preclinical\n              <jats:styled-content style=\"fixed-case\">MHD<\/jats:styled-content>\n              and identifying individuals with increased risk of progression to obesity\u2010related heart failure with preserved ejection fraction.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.118.011100","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T09:01:11Z","timestamp":1553936471000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Galectin\u20103 Is Associated With Stage B Metabolic Heart Disease and Pulmonary Hypertension in Young Obese Patients"],"prefix":"10.1161","volume":"8","author":[{"given":"Deepa M.","family":"Gopal","sequence":"first","affiliation":[{"name":"Cardiovascular Medicine Section Department of Medicine Boston University School of Medicine Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Ayalon","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine Section Department of Medicine Boston University School of Medicine Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi\u2010Chih","family":"Wang","sequence":"additional","affiliation":[{"name":"Cardiovascular Division Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Siwik","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine Section Department of Medicine Boston University School of Medicine Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Sverdlov","sequence":"additional","affiliation":[{"name":"School of Medicine and Public Health University of Newcastle New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Donohue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Perez","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine Section Department of Medicine Boston University School of Medicine Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Downing","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine Section Department of Medicine Boston University School of Medicine Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Apovian","sequence":"additional","affiliation":[{"name":"Endocrinology Section Department of Medicine Boston University School of Medicine Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Silva","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine Section Department of Medicine Boston University School of Medicine Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Panagia","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine Section Department of Medicine Boston University School of Medicine Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya","family":"Kolachalama","sequence":"additional","affiliation":[{"name":"Computational Biomedicine Department of Medicine Boston University School of Medicine Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Ho","sequence":"additional","affiliation":[{"name":"Division of Cardiology Department of Medicine Massachusetts General Hospital Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang\u2010seng","family":"Liang","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine Section Department of Medicine Boston University School of Medicine Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noyan","family":"Gokce","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine Section Department of Medicine Boston University School of Medicine Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson S.","family":"Colucci","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine Section Department of Medicine Boston University School of Medicine Boston MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328364fb58"},{"key":"e_1_3_1_3_2","first-page":"1","article-title":"Prevalence of obesity among adults and youth: United States, 2011\u20132014","volume":"288","author":"Ogden CL","year":"2015","unstructured":"Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011\u20132014. NCHS Data Brief. 2015;288:1\u20138.","journal-title":"NCHS Data Brief"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.07.763"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020245"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31829e8807"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.114.001366"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2009.177980"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197112232852601"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2016.266106"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000490"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.20.2247"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.18.2209"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.11.030"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.197079"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2008-0151"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.000760"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.11.051"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.020207"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2016.01.011"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2005.10.005"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.169404"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19381"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2014.10.003"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2004.08.032"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2010.05.010"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2011.03.008"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.026807"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-99-6-757"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000147184.13872.0F"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.09.028"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2015.09.015"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.06.013"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.643"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.06.076"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.05.014"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1182"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.069"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.7588"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-012-9400-9"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/364209"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0607966104"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2010.538080"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.203"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.04.053"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000147181.65298.4D"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.06032"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005111"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2016.12.024"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2017.03.008"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.118.011100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T11:44:23Z","timestamp":1715600663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.118.011100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,4,2]]}},"alternative-id":["10.1161\/JAHA.118.011100"],"URL":"https:\/\/doi.org\/10.1161\/jaha.118.011100","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,2]]},"assertion":[{"value":"2018-09-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e011100"}}